Antigen News and Research

RSS

Henry Ford Cancer Institute treats its first patient with CAR T-cell therapy

Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer.

18 Jun 2019

A 'health number' that could tell about prostate disease

When it comes to staying on top of your health, doctors often tell you how important it is to "know your numbers." Blood pressure, cholesterol and body mass index can tell you a lot about your heart health, but if you're a man, you need to know one more - your PSA, or prostate-specific antigen.

18 Jun 2019

Scientists turn type A blood into universal type O, potentially doubling blood transfusion stocks

Researchers have developed a technique for turning type A blood into universal type O blood. The development could boost blood stocks dramatically.

13 Jun 2019

UCLA physicians find more effective method for detecting prostate cancer

Each year, 1 million men in the U.S. undergo biopsies to determine whether they have prostate cancer. The biopsy procedure traditionally has been guided by ultrasound imaging, but this method cannot clearly display the location of tumors in the prostate gland.

12 Jun 2019

Genetic variations linked with persistence of immunity after routine childhood vaccination

A genome-wide search in thousands of children in the UK and Netherlands has revealed genetic variants associated with differing levels of protective antibodies produced after routine childhood immunizations.

12 Jun 2019

Biomarker correlates with prostate cancer aggressiveness and predicts metastasis to bone

Mortality due to prostate cancer is usually related to its likelihood to metastasize, especially to bone. Prognostic biomarkers are urgently needed to predict disease aggression so that appropriate treatment can be selected.

12 Jun 2019

Plant-derived siRNAs could bring a 'green revolution' in RNAi tools and therapeutics

"Green revolution" in the early 1950s, the extensive cultivation of Dwarf Rice solves the food problem in developing countries. At present, chronic infection with hepatitis B virus (HBV) has been a major public health problem.

11 Jun 2019

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Bruker Daltonics has launched a novel timsTOF fleX mass spectrometer which combines ESI/MALDI capability for SpatialOMx on a single instrument.

From Bruker Life Sciences Mass Spectrometry 10 Jun 2019

A novel approach to intraplaque mast cell characterization in atherosclerosis

Researchers have devised a new flow-cytometric method to identify a subpopulation of intraplaque mast cells, the primary immune mediators of atherosclerosis.

6 Jun 2019

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer, according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology, during the American Society of Clinical Oncology Annual Meeting.

3 Jun 2019

Only few prostate cancer patients choosing active surveillance follow monitoring guidelines

Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that just 15 percent of a group of men in North Carolina with early-stage prostate cancer who choose active surveillance instead of treatment followed the recommended monitoring guidelines.

3 Jun 2019

New diagnostic tool helps develop improved RDTs and support public health surveillance

PATH and Quansys Biosciences, Inc. have announced the launch of a new diagnostic tool designed to help researchers develop more sensitive and reliable malaria rapid diagnostic tests and to support public health surveillance.

31 May 2019

Expedeon announces addition of CaptSure DIY ELISA to immunoassay product portfolio

CaptSure DIY ELISA will complement Expedeon AG’s product offering, as the Company announced today. The technology was developed by TGR BioSciences, which was acquired by Expedeon in May 2018.

29 May 2019

Genetically eliminating TOX factors improves eradication of solid tumors in CAR T model

A decade ago researchers announced development of a cancer immunotherapy called CAR (for chimeric antigen receptor)-T, in which a patient is re-infused with their own genetically modified T cells equipped to mount a potent anti-tumor attack.

28 May 2019

Prostate cancer marker activates growth factors that contribute to tumor spread

A new study indicates that PSA, a prostate cancer marker, is one of the catalysts that activate vascular endothelial and lymphangiogenic growth factors which contribute to the spread of cancer.

25 May 2019

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

At a time when a growing number of men with prostate cancer considered "low risk" are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less likely than white men to adopt an active surveillance strategy for their disease.

23 May 2019

Researchers develop new microfluidic device to capture tumor cells

Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers in the University of Georgia College of Engineering followed in developing a new microfluidic device that separates elusive circulating tumor cells from a sample of whole blood.

17 May 2019

Antigen News and Research

Henry Ford Cancer Institute treats its first patient with CAR T-cell therapy

A 'health number' that could tell about prostate disease

Scientists turn type A blood into universal type O, potentially doubling blood transfusion stocks

UCLA physicians find more effective method for detecting prostate cancer

Genetic variations linked with persistence of immunity after routine childhood vaccination

Biomarker correlates with prostate cancer aggressiveness and predicts metastasis to bone

Plant-derived siRNAs could bring a 'green revolution' in RNAi tools and therapeutics

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

A novel approach to intraplaque mast cell characterization in atherosclerosis

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Only few prostate cancer patients choosing active surveillance follow monitoring guidelines

New diagnostic tool helps develop improved RDTs and support public health surveillance

Expedeon announces addition of CaptSure DIY ELISA to immunoassay product portfolio

Genetically eliminating TOX factors improves eradication of solid tumors in CAR T model

Prostate cancer marker activates growth factors that contribute to tumor spread

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

Researchers develop new microfluidic device to capture tumor cells

Neurological Side Effects of CAR T-Cell Therapy Revealed

Autophagy of dendritic cells supports T-cell anticancer activity

Slow-release HIV vaccine shows promise in preclinical trials

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News